Literature DB >> 32838154

Higher Obesity Trends Among African Americans Are Associated with Increased Mortality in Infected COVID-19 Patients Within the City of Detroit.

Smart Asare1,2, Aubin Sandio1, Ijeoma Nnodim Opara3, Latonya Riddle-Jones3, Mohan Palla4, Nkechi Renny5, Eric Ayers3.   

Abstract

As the city of Detroit raids itself of deaths by shifting from homicides, COVID-19 infection continues to harrow the city with more deaths. From March 19 to May 15, more Detroiters died in 2 months than were killed in 2 years of city homicides. African Americans or Blacks (highest-risk phenotypes) developing COVID-19 infection are more likely to die disproportionately. The confluence of diabetes, hypertension, cardiovascular disease, and the higher prevalence of obesity among Blacks have provided the needed environment for viruses like COVID-19 to thrive and cause serious infections. The purpose of this study is to connect mortality rates from COVID-19 infection to increasing obesity trends among African Americans within the city of Detroit. Statistical analyses were conducted using SPSS ver. 23. Results showed that the highest mortality rates among African Americans occurred more in the obese individuals infected with COVID-19 in the city of Detroit. Out of 1930 deaths from COVID-19 infections, 733 deaths were due to obesity alone in patients without reported comorbid conditions like diabetes, hypertension, and cardiovascular disease. Mortality rate for both male and female African Americans amounted to a total of 11.9%. Thirty-eight percent of reported COVID-19-infected African Americans were obese. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  African Americans; COVID-19 virus; Detroit; Mortality; Obesity

Year:  2020        PMID: 32838154      PMCID: PMC7324487          DOI: 10.1007/s42399-020-00385-y

Source DB:  PubMed          Journal:  SN Compr Clin Med        ISSN: 2523-8973


Introduction

COVID-19 is an acute infectious respiratory disease caused by infection with coronavirus subtype SARS-CoV-2. Transmission happens through respiratory droplets mainly via sneezing, coughing, not washing of hands after long periods, and rubbing unwashed hands on eyes, just to name a few. The disease has a wide spectrum of severity, starting with mild symptoms that can progress to more severe courses. Patients start presenting with dry cough, difficulty of breathing or dyspnea, fever, headache, fatigue, and with some presenting with loss of smell/taste. Obesity can cause activation and dysregulation of the immune system through the release of cytokines like tumor necrosis factor (TNF-α), IL-1β, and IL-6 which can cause acute inflammatory response [1]. Inflammation triggers unsustainable immune response to viral infections [1] like COVID-19; hence, these very high levels of cytokines (cytokine storm) [1] can promote organ failure and raise mortality rates among obese African Americans. Clinical courses can happen between developing mild symptoms and life-threatening complications which can include acute respiratory distress syndrome (ARDS), aseptic shock, and with some patients suffering organ failure. Patients who experience severe disease symptoms often present with dyspnea, cyanosis, mental status changes, chest uneasiness, and increased respiratory rates of ˃ 22/min along with respiratory distress of SPO2 ≤ 93%. Severe symptoms need admissions with close monitoring since currently no definite treatment option exists. Men and women are equally affected [2] across all racial groups; however, the African American obese population within the city of Detroit, Michigan, has a higher mortality rate. SARS-CoV-2 is a subfamily of enveloped nonsegmented positive-sense RNA viruses that cause respiratory tract infections that can range from mild to severe courses [1]. SARS-CoV-2 shares 79.5% identity to the SARS-CoV genome [1]. The virus invades host cells via angiotensin-converting enzyme 2 (ACE2) [1]. Increased concentrations of ACE2, which is expressed in the surface epithelium of the lungs, heart, and mucous membranes of gastrointestinal tract (hence could explain diarrhea symptoms) and upper respiratory tract (could be responsible for continuous viral shedding), play a role in the pathogenesis of COVID-19 [1].

Methodology

From March 19 to May 15, 2020, Detroit City had 16,526 confirmed cases and 1930 deaths from COVID-19 infections in the city of Detroit in Wayne County [3]. Total deaths as of May 15, 2020, in Michigan reported were 4825 [3]. Data for COVID-19 and obese patients with BMI (BMI; weight (in Kg)/height (in m2) were collected from the official Detroit City Public Health website starting March 19 to May 15, 2020 [4]. Statistical analyses were conducted using SPSS ver. 23. This public health data also televises all COVID-19 cases, as well as hospitalizations and deaths. Death by race, gender, and ethnicity was updated on May 15, 2020, each day at 3:00 pm EST or when earliest update was available.

Discussion

Italic data signify pertinent points about the paper Based on data collection and analysis using SPSS ver. 23, the results showed that out of 50,079 cases confirmed in the state of Michigan, 16,526 Blacks had confirmed COVID-19 cases in Detroit, Wayne County. Males and females were 8265 and 8261, respectively. A total of 6280 individuals of the 16,526 were obese with 3142 representing obese males and 3138 being obese females. Out of 1930 Blacks death, 733 of these patients were obese, that is, BMI ≥ 30 ≤ 34.9 for both males and females. This accounts for 38% of total deaths being associated with obesity alone. The remaining 62% had COVID-19 with other comorbidities like renal failure just to name a few and do not specifically fit the classification of obesity. Mortality rates are closely related for males and females with the total for both sexes being 11.90%. Though some studies have proposed that severely obese patients with BMI ≥ 40 are at a high risk for severe courses of COVID-19 infection, our results showed that African Americans in particular with BMI ≥ 30 ≤ 34.9 not only had severe courses of COVID-19 infection but also higher mortality rates. Seven hundred thirty-three deaths out of 1930 total Blacks’ death occurred in COVID-19-infected obese group. Reasons could be management and compliance options available for obese and severe obese patients and not seeking care with fear of being reinfected with COVID-19. That is, severely obese patients tend to benefit from multiple medication regimens to control their obesity, while some patients who are obese might be managed with supportive care. Life situations can occur where, for example, regular exercising can be skipped especially during COVID-19 pandemic. Some patients might be under stress and be depressed, as well as lack financial support to seek adequate care and as such patients can become vulnerable for cytokine storm (obesity and COVID-19 overly revving up immunoglobulins) and organ failure which raises their mortality. Physiologic effects of hormones where cortisol levels shoot up especially under immense stress cannot be ruled out. It has been medically established that hormones like cortisol put a person’s immune system at higher risk for infections since it reduces the body’s ability to fight viruses like COVID-19. Mortality rates are greatly heightened for African Americans with age > 60 years with the most lethal rates occurring among obese individuals with age > 80 years [5]. Some studies reported a 15% mortality rate for the general public [5]. Our study and analysis resulted in 11.90% mortality for the African American community in Detroit. In the state of Michigan, 33% of COVID-19 cases and 40% of deaths have occurred among Black individuals, who represent 14% of the population [6]. These glaring numbers calls for more research and emphasis in the African American community across the USA.

Conclusion

Clinical science flow has set the platform for more learning about which individuals and groups experience the direst complications. Blacks residing in poor communities in Detroit have high housing densities, high crime rates, poor access to healthy foods, and low socioeconomic status. Obesity alone is a risk factor for mortality regardless of the previously mentioned factors. Not obesity alone but now obese African Americans who get infected with COVID-19 are at an even higher risk for mortality. (XLSX 10 kb).
BlacksMalesFemalesTotals
Ages25–65 years25–65 years
Sex population8265826116,526
Obese sex population314231386280
BMI≥ 30 but ≤ 34.9≥ 30 but ≤ 34.9≥ 30 but ≤ 34.9
Obesity (% for both sexes)38%38%38%
Mortality rate percentage (%) 5.95% 5.94% 11.90%
P value for obese< 0.005< 0.006

Italic data signify pertinent points about the paper

  1 in total

Review 1.  Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review.

Authors:  Kaviyarasi Renu; Pureti Lakshmi Prasanna; Abilash Valsala Gopalakrishnan
Journal:  Life Sci       Date:  2020-05-22       Impact factor: 6.780

  1 in total
  5 in total

1.  Obesity-Related Health Lifestyles of Late-Middle Age Black Americans: The Jackson Heart Study.

Authors:  William C Cockerham; Shawn Bauldry; Mario Sims
Journal:  Am J Prev Med       Date:  2022-07       Impact factor: 6.604

2.  Non-hospitalized Adults with COVID-19 Differ Noticeably from Hospitalized Adults in Their Demographic, Clinical, and Social Characteristics.

Authors:  Sharon H Bergquist; Clyde Partin; David L Roberts; James B O'Keefe; Elizabeth J Tong; Jennifer Zreloff; Thomas L Jarrett; Miranda A Moore
Journal:  SN Compr Clin Med       Date:  2020-08-14

Review 3.  Leptin in the Respiratory Tract: Is There a Role in SARS-CoV-2 Infection?

Authors:  Andreina Bruno; Giuliana Ferrante; Serena Di Vincenzo; Elisabetta Pace; Stefania La Grutta
Journal:  Front Physiol       Date:  2021-12-22       Impact factor: 4.566

4.  Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age.

Authors:  J Fabião; B Sassi; E F Pedrollo; F Gerchman; C K Kramer; C B Leitão; L C Pinto
Journal:  Braz J Med Biol Res       Date:  2022-02-16       Impact factor: 2.590

Review 5.  Medical complications of obesity: heightened importance in a COVID era.

Authors:  Heather Prendergast; Carissa Tyo; Christopher Colbert; Morgan Kelley; Ruth Pobee
Journal:  Int J Emerg Med       Date:  2022-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.